BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Intercept Pharmaceuticals 



New York City  New York    U.S.A.
Phone: n/a Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Intercept Pharmaceuticals (ICPT) Announces New Data Analyses From FLINT Trial Of Obeticholic Acid In NASH 3/20/2015 7:24:58 AM
Intercept Pharmaceuticals (ICPT) Announces 2014 Financial Results 3/2/2015 7:38:30 AM
Intercept Pharmaceuticals (ICPT) To Report Full Year 2014 Financial Results On March 2 And Present At Upcoming Conferences 2/23/2015 8:02:09 AM
Intercept Pharmaceuticals (ICPT) Announces Promotion Of Lisa Bright To Chief Commercial & Corporate Affairs Officer 2/20/2015 7:41:42 AM
Intercept Pharmaceuticals (ICPT) Announces Completion Of Public Offering And Exercise Of Option To Purchase Additional Shares 2/11/2015 7:35:29 AM
Intercept Pharmaceuticals (ICPT) Announces Pricing Of Public Offering 2/5/2015 11:13:18 AM
Intercept Pharmaceuticals (ICPT) Announces Proposed Public Offering Of Common Stock 2/4/2015 7:39:41 AM
Intercept Pharmaceuticals (ICPT) Receives Breakthrough Therapy Designation From FDA For Obeticholic Acid For Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis 1/30/2015 8:43:18 AM
Intercept Pharmaceuticals (ICPT) Rockets as Lead NASH Drug Snags Breakthrough Status From the FDA 1/30/2015 6:17:48 AM
Intercept Pharmaceuticals (ICPT) Provides 2014 Year-End Update And Planned 2015 Milestones 1/12/2015 8:00:56 AM
123456789